2 most recent filings and news items mentioning IVF. Updated every 60 seconds.
EarningsJun 22, 2026Positive
INVO Fertility achieved $2.0 million in Q1 2026 revenue, up 23% year-over-year, while eliminating all Series C-2 Preferred Stock and warrant liabilities to improve its capital structure. The company's stockholders' equity nearly doubled to $15.0 million, demonstrating financial s
View filing at SEC.gov →
EarningsJun 2, 2026Positive
INVO Fertility posted fiscal 2025 revenue of $6.8 million, a 5% increase year-over-year, while net losses from continuing operations improved to $5.3 million from $7.7 million. The company strengthened its balance sheet through $11.5 million in financing, acquired a fourth fertil
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.